Topics
Low-grade gliomas | Treatment | Targeted therapy | Erdafitinib
Home > Publications > Topics > Low-grade gliomas > Treatment > Targeted terapy > Erdafitinib
Carranza O, Pant S, Schuler M, Witt O, Geoerger B, Loriot Y,
Farouk Sait S, Arnold D, Dal Molin GZ, Lugowska I, Winter H,
Baldini C, Corassa M, Thomas S, Crow L, Xia Y, Triantos S, Sweiti
H, Reardon DA.
Erdafitinib in Patients
With Advanced Solid Tumors With FGFR
Alterations (RAGNAR): Results of Tumor-Specific Analyses and
Secondary Cohorts.
JCO
Precis Oncol. 2026 Jul 15;10(7):e2501094. doi:
10.1200/PO-25-01094. PMID:
42456086. Trial
registration ID: NCT04083976. ˍ